Potcast 173: Cannabis and Brain Injury Research

Potcast 173 features one of my favorite cannabis scientists to talk about brain injuries and the use of cannabis as a treatment tool. You last met Dr. Linda Klumpers during our discussion about tolerance breaks and cannabis during pregnancy on Potcast 155. 

Today Linda and I discuss the basics of brain injury and the varying cognitive and emotional effects. We explore the pitfalls of diagnosing brain injury, what the existing research suggests about cannabis as a neuro-protectant, and the politics blocking researchers and folks like you and me from learning more. I also ask Linda about the long-term implications of head trauma on adult brains and the developing brains of kids. Not everything we talk about is comfortable but everyone deserves the insight to make informed decisions.

Please share the love by rating and reviewing Casually Baked on iTunes or Apple Podcasts. These little acts of support might only take a few seconds of your time, but make a huge impact in helping others find this highly responsible cannabis content. 

Puff puff, pass it on. 💚✨ -Jo

Today’s Potcast is Lit By White Ash Group

For you cannabis industry trailblazers leading the way, White Ash Group provides top tier talent and tailored hiring solutions for Multi-State Operators, LPs, the vape and tech industries, retail operations, product, and lifestyle brands. From seed …

For you cannabis industry trailblazers leading the way, White Ash Group provides top tier talent and tailored hiring solutions for Multi-State Operators, LPs, the vape and tech industries, retail operations, product, and lifestyle brands. From seed to sale, roots to suits, and everything in between, White Ash Group delivers pre-screened, pre-vetted candidates fast. Understanding the cannabis culture is invaluable in a new hire. If your company is in building mode, click this link to learn more. Tell 'em Jo sent you.

‘After the Show’ Notes

Connect with Dr. Linda Klumpers on LinkedIn.B2C: Become part of Cannify's testing panel and get first access to course materials for free. To redeem, e-mail info@cannify.us with the subject line of 'Casually Baked' and tell us you are interested in …

Connect with Dr. Linda Klumpers on LinkedIn.

B2C: Become part of Cannify's testing panel and get first access to course materials for free. To redeem, e-mail info@cannify.us with the subject line of 'Casually Baked' and tell us you are interested in the testing panel.

B2B: Get a free educational quiz to send out to your loyalty program subscribers that you can use for a product raffle. To redeem, e-mail info@cannify.us with the subject line of 'Casually Baked' and tell us you are interested in the raffle quiz.

Linda Klumpers has a Ph.D. in cannabis pharmacology and has spent her career studying cannabinoids, the endocannabinoid system and their effects on humans. Linda is co-founder of Verdient Science specializing in cannabinoid science and research. She’s also the creator of Cannify, an online educational tool for making cannabis science approachable and useful for the individual consumer. Linda has 14-years of clinical research in cannabis and she’s co-authored ten peer-reviewed publications in the field of cannabinoids. Linda splits her time and research studies between her current home in Colorado, and where she was born and raised in the Netherlands.

Cannify.us. is an online educational tool for making cannabis science approachable and useful for you as the consumer. Cannify is a one-stop-shop for cannabis research. Do your homework there and easily save relevant information to review with your doctor or medical professional. And take the basic Cannify quiz linked below to personalize your cannabis experience.

Cannabidiol for PTSD and TBI

As Dr. Klumpers and I discuss on the potcast, there are not nearly enough studies exploring TBI and CTE. Here’s the one upcoming study she mentioned.

The proposed study is an eight-week double-blind randomized placebo-controlled parallel dose-finding study of CBD's effects on PTSD symptoms and neurocognitive function in 120 patients with moderate to severe PTSD, 50% with comorbid mild-moderate TBI. There will be three arms, CBD 400 mg daily (n=40); CBD 600 mg daily (n=40) and placebo daily (n=40).